Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Detection of cervical lymph node micrometastasis and isolated tumor cells in oral squamous cell carcinoma using immunohistochemistry and serial sectioning.

Dhawan I, Sandhu SV, Bhandari R, Sood N, Bhullar RK, Sethi N.

J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):436-444.

2.

Assessment of lymph node involvement in colorectal cancer.

Ong ML, Schofield JB.

World J Gastrointest Surg. 2016 Mar 27;8(3):179-92. doi: 10.4240/wjgs.v8.i3.179. Review.

3.

Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis.

Zeng YJ, Zhang CD, Dai DQ.

World J Gastroenterol. 2015 Feb 7;21(5):1628-35. doi: 10.3748/wjg.v21.i5.1628. Review.

4.

Clinical impact of minimal cancer cell detection in various colorectal cancer specimens.

Yoshimatsu K, Yokomizo H, Naritaka Y.

World J Gastroenterol. 2014 Sep 21;20(35):12458-61. doi: 10.3748/wjg.v20.i35.12458. Review.

5.

Prognostic relevance of minimal residual disease in colorectal cancer.

Bork U, Grützmann R, Rahbari NN, Schölch S, Distler M, Reissfelder C, Koch M, Weitz J.

World J Gastroenterol. 2014 Aug 14;20(30):10296-304. doi: 10.3748/wjg.v20.i30.10296. Review.

6.

Occult neoplastic cells in lymph node sinuses and recurrence/metastasis of stage II/III gastric cancer.

Sekido Y, Mukai M, Yamazaki M, Tajima T, Yamamoto S, Hasegawa S, Kishima K, Tajiri T, Nakamura N.

Oncol Lett. 2014 Jan;7(1):53-58.

7.

Myofibroblast activation in colorectal cancer lymph node metastases.

Yeung TM, Buskens C, Wang LM, Mortensen NJ, Bodmer WF.

Br J Cancer. 2013 May 28;108(10):2106-15. doi: 10.1038/bjc.2013.209.

8.

GUCY2C molecular staging personalizes colorectal cancer patient management.

Gong JP, Schulz S, Hyslop T, Waldman SA.

Biomark Med. 2012 Jun;6(3):339-48. doi: 10.2217/bmm.12.24. Review.

9.

Molecular staging individualizing cancer management.

Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA.

J Surg Oncol. 2012 Apr 1;105(5):468-74. doi: 10.1002/jso.21858. Review.

10.

Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.

Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE, Stojadinovic A.

Ann Surg. 2010 Sep;252(3):467-74; discussion 474-6. doi: 10.1097/SLA.0b013e3181f19767.

11.

Ultrastaging of lymph node in uterine cancers.

Bézu C, Coutant C, Ballester M, Feron JG, Rouzier R, Uzan S, Daraï E.

J Exp Clin Cancer Res. 2010 Jan 21;29:5. doi: 10.1186/1756-9966-29-5. Review.

12.

GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.

Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA.

Expert Rev Mol Diagn. 2009 Nov;9(8):777-85. doi: 10.1586/erm.09.67.

13.

Clinical significance of lymph node micrometastasis in stage I and II colon cancer.

Park SJ, Lee KY, Kim SY.

Cancer Res Treat. 2008 Jun;40(2):75-80. doi: 10.4143/crt.2008.40.2.75.

14.

Previstage GCC test for staging patients with colorectal cancer.

Mejia A, Waldmana SA.

Expert Rev Mol Diagn. 2008 Sep;8(5):571-8. doi: 10.1586/14737159.8.5.571.

15.

Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater.

Scheunemann P, Stoecklein NH, Rehders A, Bidde M, Metz S, Peiper M, Eisenberger C, Schulte Am Esch J, Knoefel WT, Hosch SB.

HPB (Oxford). 2007;9(2):135-9. doi: 10.1080/13651820601090646.

16.

Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature.

Nicastri DG, Doucette JT, Godfrey TE, Hughes SJ.

J Mol Diagn. 2007 Nov;9(5):563-71. Review.

17.

The sentinel node procedure in colon carcinoma: a multi-centre study in The Netherlands.

Kelder W, Braat AE, Karrenbeld A, Grond JA, De Vries JE, Oosterhuis JW, Baas PC, Plukker JT.

Int J Colorectal Dis. 2007 Dec;22(12):1509-14.

18.

Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.

Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM.

Ann Surg. 2007 Jun;245(6):858-63.

19.

Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.

Stojadinovic A, Nissan A, Protic M, Adair CF, Prus D, Usaj S, Howard RS, Radovanovic D, Breberina M, Shriver CD, Grinbaum R, Nelson JM, Brown TA, Freund HR, Potter JF, Peretz T, Peoples GE.

Ann Surg. 2007 Jun;245(6):846-57.

20.

ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma.

Bennett MA, Kay EW, Mulcahy H, O'flaherty L, O'donoghue DP, Leader M, Croke DT.

Clin Mol Pathol. 1995 Dec;48(6):M310-5.

Items per page

Supplemental Content

Support Center